title: Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
authors.affiliation: Pittsburgh Transplantation Institute, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: R
authors.initials: R
authors.lastname: Selby
authors.forename: O
authors.initials: O
authors.lastname: Bronsther
authors.forename: H
authors.initials: H
authors.lastname: Doyle
authors.forename: T
authors.initials: T
authors.lastname: Gayowski
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus